Search

everythinglearnresearchcommunity

for

Search:↓

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Analog 23 is a promising compound for prostate cancer treatment.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Blocking a protein called prostaglandin D2 might help treat hair loss.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New progesterone-based compounds can block male hormones.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Progesterone's anesthetic effects don't rely on progesterone receptors.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

More research is needed to understand if GLP-1 agonists affect hair health.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Allopregnanolone helps control oxytocin levels during pregnancy to prevent preterm labor.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.